{"id":"W3001664763","doi":"10.1007/s10620-019-06036-0","title":"Systematic Review: Non-medical Switching of Infliximab to CT-P13 in Inflammatory Bowel Disease","year":2020,"lang":"en","type":"review","venue":"Digestive Diseases and Sciences","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":33,"is_retracted":false,"has_abstract":true,"ca_institutions":"London Health Sciences Centre; Western University; University of Alberta; Université de Montréal","funders":"Janssen Canada","keywords":"Biosimilar; Observational study; Medicine; Infliximab; Randomized controlled trial; Inflammatory bowel disease; Ulcerative colitis; Clinical trial; Intensive care medicine; Disease; Hepatology; Internal medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008982115,0.0003903498,0.002390086,0.0002181713,0.0001263268,0.00003885437,0.0006434825,0.0001355983,0.0000752807],"category_scores_gemma":[0.004161614,0.0002374845,0.0004090628,0.0005793637,0.0005234168,0.00008362071,0.0003357321,0.0003498579,0.00003414695],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003367837,"about_ca_system_score_gemma":0.0007074948,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001555743,"about_ca_topic_score_gemma":9.472091e-7,"domain_scores_codex":[0.9970639,0.0006440141,0.001070381,0.000649753,0.0002054418,0.0003665495],"domain_scores_gemma":[0.9980818,0.0009023238,0.000391945,0.0002474187,0.0000534464,0.0003230709],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.00002186185,0.000187478,0.007077723,0.925009,0.0002596011,0.0002062728,0.00007444102,4.536947e-7,0.000003023708,0.0004708003,0.0004838357,0.06620558],"study_design_scores_gemma":[0.0002709925,0.0001989103,0.007942513,0.9247587,0.002875774,0.00003578015,0.0001182662,0.0000315873,0.000001705141,0.00007700674,0.06303119,0.0006575461],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003736998,0.9973716,0.00001744103,0.0004385359,0.0001681253,0.001392682,0.0001482103,0.00001607832,0.0000736747],"genre_scores_gemma":[0.00110291,0.9978428,0.00003048441,0.0007837543,0.00002344905,0.000156058,0.00001519498,0.00001200978,0.00003337353],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.06554803,"threshold_uncertainty_score":0.9684336,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02185699071376619,"score_gpt":0.3437954861377051,"score_spread":0.3219384954239389,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}